The Journal of Immunology, Vol 156, Issue 4 1333-1338, Copyright © 1996 by American Association of Immunologists

ARTICLES

IL-7 differentially modulates the expression of IFN-gamma and IL-4 in activated human T lymphocytes by transcriptional and post- transcriptional mechanisms

P Borger, HF Kauffman, DS Postma and E Vellenga
Department of Medicine, University of Groningen, The Netherlands.

We investigated the role of IL-7 on the expression of IFN-gamma and IL- 4 in human T lymphocytes. IL-7 alone did not induce IFN-gamma or IL-4 mRNA. However, IL-7 dose-dependently up-regulates the anti-CD3- or anti- CD3/anti-CD28-induced IFN-gamma and IL-4 mRNA expression. Used at an optimal concentration, IL-7 (5 ng/ml) increased the accumulation of IFN- gamma (eightfold) and IL-4 (2.5-fold) mRNAs, which could not be blocked by anti-IL-12 treatment. The enhanced IFN-gamma mRNA accumulation was observed within 3 to 6 h, without altering the pattern of the kinetics. However, longer exposure (> 12 h) did not result in different IFN-gamma expression for anti-CD3/anti-CD28 vs anti-CD3/anti-CD28 plus IL-7- stimulated T lymphocytes. mRNA stability studies revealed that IL-7 stabilizes both IFN-gamma and IL-4 mRNA transcripts: 40 and 60 min in anti-CD3/anti-CD28-stimulated T cells vs 120 and 90 min in T cells costimulated with anti-CD3/anti-CD28 plus IL-7. Nuclear run-on assays revealed that the transcription rate of the IFN-gamma gene increased approximately twofold in the presence of IL-7, without affecting the transcription rate of the IL-4 gene. The IL-7-mediated IFN-gamma up- regulation could not be inhibited by cycloheximide treatment, in contrast to IL-4 gene expression. However, the promotive effect of IL-7 on IFN-gamma and IL-4 gene expression could be blocked by genistein and cyclosporin A. Finally, it was demonstrated that the effect of IL-7 on IFN-gamma mRNA accumulation was also reflected at the protein level. In summary, these data demonstrate that IL-7 preferentially up-regulates IFN-gamma expression in activated T lymphocytes, which is accomplished at transcriptional and post-transcriptional levels.

This article has been cited by other articles:

				H. Yang, B. Madison, D. L. Gumucio, and D. H. Teitelbaum Specific overexpression of IL-7 in the intestinal mucosa: the role in intestinal intraepithelial lymphocyte development Am J Physiol Gastrointest Liver Physiol, June 1, 2008; 294(6): G1421 - G1430. [Abstract] [Full Text] [PDF]

				S. M. Churchman and F. Ponchel Interleukin-7 in rheumatoid arthritis Rheumatology, June 1, 2008; 47(6): 753 - 759. [Abstract] [Full Text] [PDF]

				T. O. Yarovinsky, N. S. Butler, M. M. Monick, and G. W. Hunninghake Early Exposure to IL-4 Stabilizes IL-4 mRNA in CD4+ T Cells via RNA-Binding Protein HuR J. Immunol., October 1, 2006; 177(7): 4426 - 4435. [Abstract] [Full Text] [PDF]

				K. Fukatsu, T. Moriya, F. Ikezawa, Y. Maeshima, J. Omata, Y. Yaguchi, K. Okamoto, H. Mochizuki, H. Hiraide, and G. Hardy Interleukin-7 Dose-Dependently Restores Parenteral Nutrition-Induced Gut-Associated Lymphoid Tissue Cell Loss but Does Not Improve Intestinal Immunoglobulin A Levels JPEN J Parenter Enteral Nutr, September 1, 2006; 30(5): 388 - 394. [Abstract] [Full Text] [PDF]

				J. Harnaha, J. Machen, M. Wright, R. Lakomy, A. Styche, M. Trucco, S. Makaroun, and N. Giannoukakis Interleukin-7 Is a Survival Factor for CD4+ CD25+ T-Cells and Is Expressed by Diabetes-Suppressive Dendritic Cells Diabetes, January 1, 2006; 55(1): 158 - 170. [Abstract] [Full Text] [PDF]

				M. R. Ryan, R. Shepherd, J. K. Leavey, Y. Gao, F. Grassi, F. J. Schnell, W.-P. Qian, G. J. Kersh, M. N. Weitzmann, and R. Pacifici An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency PNAS, November 15, 2005; 102(46): 16735 - 16740. [Abstract] [Full Text] [PDF]

				M. M. W. Chong, Y. Chen, R. Darwiche, N. L. Dudek, W. Irawaty, P. Santamaria, J. Allison, T. W. H. Kay, and H. E. Thomas Suppressor of Cytokine Signaling-1 Overexpression Protects Pancreatic {beta} Cells from CD8+ T Cell-Mediated Autoimmune Destruction J. Immunol., May 1, 2004; 172(9): 5714 - 5721. [Abstract] [Full Text] [PDF]

				M. Gendelman, T. Hecht, B. Logan, S. Vodanovic-Jankovic, R. Komorowski, and W. R. Drobyski Host Conditioning Is a Primary Determinant in Modulating the Effect of IL-7 on Murine Graft-versus-Host Disease J. Immunol., March 1, 2004; 172(5): 3328 - 3336. [Abstract] [Full Text] [PDF]

				A. E. C. Broers, S. J. Posthumus-van Sluijs, H. Spits, B. van der Holt, B. Lowenberg, E. Braakman, and J. J. Cornelissen Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants Blood, August 15, 2003; 102(4): 1534 - 1540. [Abstract] [Full Text] [PDF]

				C. Bello-Fernandez, J. Stasakova, A. Renner, N. Carballido-Perrig, M. Koening, M. Waclavicek, O. Madjic, L. Oehler, O. Haas, J. M. Carballido, et al. Retrovirus-mediated IL-7 expression in leukemic dendritic cells generated from primary acute myelogenous leukemias enhances their functional properties Blood, March 15, 2003; 101(6): 2184 - 2190. [Abstract] [Full Text] [PDF]

				J A G van Roon, K A F M Glaudemans, J W J Bijlsma, and F P J G Lafeber Interleukin 7 stimulates tumour necrosis factor {alpha} and Th1 cytokine production in joints of patients with rheumatoid arthritis Ann Rheum Dis, February 1, 2003; 62(2): 113 - 119. [Abstract] [Full Text] [PDF]

				N. Giuliani, S. Colla, R. Sala, M. Moroni, M. Lazzaretti, S. La Monica, S. Bonomini, M. Hojden, G. Sammarelli, S. Barille, et al. Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease Blood, December 15, 2002; 100(13): 4615 - 4621. [Abstract] [Full Text] [PDF]

				T. J. Fry and C. L. Mackall Interleukin-7: from bench to clinic Blood, May 13, 2002; 99(11): 3892 - 3904. [Full Text] [PDF]

				R. Gonsky, R. L. Deem, J. H. Bream, D. H. Lee, H. A. Young, and S. R. Targan Mucosa-Specific Targets for Regulation of IFN-{gamma} Expression: Lamina Propria T Cells Use Different cis-Elements than Peripheral Blood T Cells to Regulate Transactivation of IFN-{gamma} Expression J. Immunol., February 1, 2000; 164(3): 1399 - 1407. [Abstract] [Full Text] [PDF]

				A. Hameg, C. Gouarin, J.-M. Gombert, S. Hong, L. Van Kaer, J.-F. Bach, and A. Herbelin IL-7 Up-Regulates IL-4 Production by Splenic NK1.1+ and NK1.1- MHC Class I-Like/CD1-Dependent CD4+ T Cells J. Immunol., June 15, 1999; 162(12): 7067 - 7074. [Abstract] [Full Text] [PDF]

				G Monteleone, T Parrello, F Luzza, and F Pallone Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7 Gut, November 1, 1998; 43(5): 620 - 628. [Abstract] [Full Text] [PDF]

				P. Borger, Y. Hoekstra, M. T. Esselink, D. S. Postma, J. Zaagsma, E. Vellenga, and H. F. Kauffman beta -Adrenoceptor-mediated Inhibition of IFN-gamma , IL-3, and GM-CSF mRNA Accumulation in Activated Human T Lymphocytes Is Solely Mediated by the beta 2-Adrenoceptor Subtype Am. J. Respir. Cell Mol. Biol., September 1, 1998; 19(3): 400 - 407. [Abstract] [Full Text]

				P. Jeannin, Y. Delneste, S. Lecoanet-Henchoz, D. Gretener, and J.-Y. Bonnefoy Interleukin-7 (IL-7) Enhances Class Switching to IgE and IgG4 in the Presence of T Cells Via IL-9 and sCD23 Blood, February 15, 1998; 91(4): 1355 - 1361. [Abstract] [Full Text] [PDF]

				W. A. Sewell, L. L. Scurr, H. Orphanides, S. Kinder, and R. I. Ludowyke Induction of Interleukin-4 and Interleukin-5 Expression in Mast Cells Is Inhibited by Glucocorticoids Clin. Vaccine Immunol., January 1, 1998; 5(1): 18 - 23. [Abstract] [Full Text]

				S. I. Gringhuis, L. F.M.H. de Leij, E. W. Verschuren, P. Borger, and E. Vellenga Interleukin-7 Upregulates the Interleukin-2-Gene Expression in Activated Human T Lymphocytes at the Transcriptional Level by Enhancing the DNA Binding Activities of Both Nuclear Factor of Activated T Cells and Activator Protein-1 Blood, October 1, 1997; 90(7): 2690 - 2700. [Abstract] [Full Text] [PDF]